Reta/GLP-3 | Triple GIP, GLP-1 & Glucagon Agonist
Reta/GLP-3 | Triple GIP, GLP-1 & Glucagon Agonist
Reta/GLP-3 is an experimental peptide being studied for weight management, appetite, blood sugar control, liver fat, and overall metabolic health. Researchers are interested in whether targeting several of the body's hunger, energy, and blood sugar signals at once may produce different effects than targeting just one or two.
In scientific terms, retatrutide is a synthetic peptide designed to activate three metabolic hormone receptors: GIP, GLP-1, and glucagon. This triple-receptor activity distinguishes it from semaglutide, which primarily targets GLP-1, and tirzepatide, which targets GIP and GLP-1.
Product contents: Contains 30 mg total in 3 mL of liquid (10 mg/mL).
$429.00
- Stock: In Stock
- Model: Reta/GLP-3
SHIPPING
In stock orders are typically prepared and shipped within 2–3 business days after they are placed. Backorder items take 2-3 weeks to arrive.
Need dosing guidance? Please complete your Bioscience Profile to request guidance specific to your product and its concentration.
RETURNS
Due to the nature of this medical product, all sales are final. There are no refunds or exchanges. If you have a problem with your product upon delivery, please contact customer support with details and photos.
In stock orders are typically prepared and shipped within 2–3 business days after they are placed. Backorder items take 2-3 weeks to arrive.
Need dosing guidance? Please complete your Bioscience Profile to request guidance specific to your product and its concentration.
RETURNS
Due to the nature of this medical product, all sales are final. There are no refunds or exchanges. If you have a problem with your product upon delivery, please contact customer support with details and photos.
Tags:
Retatrutide
, Reta/GLP-3
, Weight Management
, Appetite
, Metabolic Health
, Blood Sugar
, GLP-1
, GIP
, Glucagon
, Triple Agonist
, Metabolic Peptides